<li>agrimony<p>agrimony increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>american ginseng<p>american ginseng increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>amitriptyline<p>amitriptyline increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>amoxapine<p>amoxapine increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>anamu<p>anamu increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>aspirin<p>aspirin increases effects of glimepiride by plasma protein binding competition. Minor/Significance Unknown. Large dose of salicylate.</p></li><li>aspirin rectal<p>aspirin rectal increases effects of glimepiride by plasma protein binding competition. Minor/Significance Unknown. Large dose of salicylate.</p></li><li>aspirin/citric acid/sodium bicarbonate<p>aspirin/citric acid/sodium bicarbonate increases effects of glimepiride by plasma protein binding competition. Minor/Significance Unknown. Large dose of salicylate.</p></li><li>balsalazide<p>balsalazide increases effects of glimepiride by plasma protein binding competition. Minor/Significance Unknown. Large dose of salicylate.</p></li><li>bendroflumethiazide<p>bendroflumethiazide decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>budesonide<p>budesonide decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>chloramphenicol<p>chloramphenicol increases levels of glimepiride by decreasing metabolism. Minor/Significance Unknown.</p></li><li>chlorothiazide<p>chlorothiazide decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>chlorthalidone<p>chlorthalidone decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>choline magnesium trisalicylate<p>choline magnesium trisalicylate increases effects of glimepiride by plasma protein binding competition. Minor/Significance Unknown. Large dose of salicylate.</p></li><li>chromium<p>chromium increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>clobetasone<p>clobetasone decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>clomipramine<p>clomipramine increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>clonidine<p>clonidine decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.<span><br><br></span>clonidine, glimepiride. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.</p></li><li>cornsilk<p>cornsilk increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).</p></li><li>cortisone<p>cortisone decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>cyclopenthiazide<p>cyclopenthiazide decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>cyclosporine<p>glimepiride increases levels of cyclosporine by unknown mechanism. Minor/Significance Unknown.</p></li><li>damiana<p>damiana decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>danazol<p>danazol increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>deflazacort<p>deflazacort decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>desipramine<p>desipramine increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>devil's claw<p>devil's claw increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>dexamethasone<p>dexamethasone decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>diflunisal<p>diflunisal increases effects of glimepiride by plasma protein binding competition. Minor/Significance Unknown. Large dose of salicylate.</p></li><li>dosulepin<p>dosulepin increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>doxepin<p>doxepin increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>elderberry<p>elderberry increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).</p></li><li>eucalyptus<p>eucalyptus increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>fludrocortisone<p>fludrocortisone decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>fluoxymesterone<p>fluoxymesterone increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>fo-ti<p>fo-ti increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>forskolin<p>forskolin increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Colenol, a compound found in Coleus root, may stimulate insulin release.</p></li><li>gotu kola<p>gotu kola increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. (Theoretical interaction).</p></li><li>guanabenz<p>guanabenz decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.<span><br><br></span>guanabenz, glimepiride. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.</p></li><li>guanfacine<p>guanfacine decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.<span><br><br></span>guanfacine, glimepiride. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.</p></li><li>gymnema<p>gymnema increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>horse chestnut seed<p>horse chestnut seed increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>hydrochlorothiazide<p>hydrochlorothiazide decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>hydrocortisone<p>hydrocortisone decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>imipramine<p>imipramine increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>indapamide<p>indapamide decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>isoniazid<p>isoniazid decreases effects of glimepiride by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>juniper<p>juniper increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).</p></li><li>lofepramine<p>lofepramine increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>lycopus<p>lycopus increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).</p></li><li>maitake<p>maitake increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).</p></li><li>maprotiline<p>maprotiline increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>mesalamine<p>mesalamine increases effects of glimepiride by plasma protein binding competition. Minor/Significance Unknown. Large dose of salicylate.</p></li><li>mesterolone<p>mesterolone increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>methyclothiazide<p>methyclothiazide decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>methylprednisolone<p>methylprednisolone decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>methyltestosterone<p>methyltestosterone increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>metolazone<p>metolazone decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>mianserin<p>mianserin increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>nettle<p>nettle increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. (Theoretical interaction).</p></li><li>nortriptyline<p>nortriptyline increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>ofloxacin<p>ofloxacin, glimepiride. Mechanism: unspecified interaction mechanism. Minor/Significance Unknown. Potential dysglycemia.</p></li><li>orlistat<p>orlistat increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>oxandrolone<p>oxandrolone increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>oxymetholone<p>oxymetholone increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>pegvisomant<p>pegvisomant increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>potassium acid phosphate<p>potassium acid phosphate increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.</p></li><li>potassium chloride<p>potassium chloride increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.</p></li><li>potassium citrate<p>potassium citrate increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.</p></li><li>prednisolone<p>prednisolone decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>prednisone<p>prednisone decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>protriptyline<p>protriptyline increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>sage<p>sage increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>salicylates (non-asa)<p>salicylates (non-asa) increases effects of glimepiride by plasma protein binding competition. Minor/Significance Unknown. Large dose of salicylate.</p></li><li>salsalate<p>salsalate increases effects of glimepiride by plasma protein binding competition. Minor/Significance Unknown. Large dose of salicylate.</p></li><li>sitagliptin<p>sitagliptin, glimepiride.
Either increases effects of the other by pharmacodynamic synergism. Minor/Significance Unknown. Risk of hypoglycemia with combination is unknown.</p></li><li>stevia<p>stevia increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>sulfasalazine<p>sulfasalazine increases effects of glimepiride by plasma protein binding competition. Minor/Significance Unknown. Large dose of salicylate.</p></li><li>tacrolimus<p>glimepiride increases levels of tacrolimus by unknown mechanism. Minor/Significance Unknown.</p></li><li>testosterone<p>testosterone increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>testosterone buccal system<p>testosterone buccal system increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>testosterone topical<p>testosterone topical increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>tongkat ali<p>tongkat ali increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Risk of hypoglycemia.</p></li><li>trazodone<p>trazodone increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>triamcinolone<p>triamcinolone decreases effects of glimepiride by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>trimipramine<p>trimipramine increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>vanadium<p>vanadium increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>willow bark<p>willow bark increases effects of glimepiride by plasma protein binding competition. Minor/Significance Unknown. Large dose of salicylate.</p></li>